It's Time For/Charity/St. Louis/Curing Type 1 Diabetes
All Video Credits are listed here http://broadcaster.beazil.net/public/credits/youtube/videos/42303 Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. According to the United States Census Bureau, St. Louis has a total area of 66 square miles (170 km2), of which 62 square miles (160 km2) is land and 4.1 square miles (11 km2) (6.2%) is water. (Not shown on simple maps of the city, the land at its airport is owned by the city, served by its fire department and others, and is an exclave of St. Louis.) The city is built primarily on bluffs and terraces that rise 100–200 feet above the western banks of the Mississippi River, in the Midwestern United States just south of the Missouri-Mississippi confluence. Much of the area is a fertile and gently rolling prairie that features low hills and broad, shallow valleys. Both the Mississippi River and the Missouri River have cut large valleys with wide flood plains. JDRF is the world’s leading charitable funder of type 1 diabetes research and raise money to drive world class research. We aim to find new ways to treat type 1 diabetes and its complications, prevent type 1 from developing and find the cure for people who already have the condition. JDRF’s research mission is to discover, develop, and deliver advances that cure, better treat, and prevent T1D. As the global leader in the fight against T1D, JDRF’s research programs are comprehensive – addressing the hopes and dreams of every person with T1D for the best quality of life and a cure for this disease. Millions of people around the world live with type 1 diabetes (T1D), a life-threatening autoimmune disease that strikes both children and adults. There is no way to prevent it, and at present, no cure. Type 1 diabetes in children used to be known as juvenile diabetes or insulin-dependent diabetes. Alternative Names of T1D: Insulin-dependent diabetes; Juvenile onset diabetes; Diabetes – type 1. Type 1 Diabetes – In type 1 diabetes, your immune system mistakenly destroys the cells in your pancreas that make insulin. Your body treats these cells as invaders and destroys them. This can happen over a few weeks, months, or years. When enough beta cells are destroyed, your pancreas stops making insulin, or makes too little insulin. Because the pancreas does not make insulin, insulin needs to be replaced. Insulin does not come in a pill. People with type 1 diabetes take insulin by injection with a syringe, an insulin pen, or an insulin pump. Without insulin, your blood glucose rises and is higher than normal, which is called hyperglycemia. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To sum up, the major issues that were mentioned are:
The Action to Control Cardiovascular Risk in Diabetes Study,diabetes mellitus,Artificial Pancreas,Carb Counting,70/30 insulin,The Automation to Simulate Pancreatic Insulin Response Trial,insulin lispro,Global Diabetes Research,impaired fasting glucose,Type 1 Diabetes,Hypoglycemia Prevention,turn Type One into Type Now,support our research,Food insecurity (FI),longer-acting sulfonylureas,undiagnosed diabetes,Scientific,Diabetes Interventions and Complications Study,ASPIRE Trial,Missouri,River City,ketosis,Jump to cure Diabetes,Heart Disease,T1D Staging,insulinoma,insulin delivery,Medical Research Council,Juvenile diabetes foundation,new treatment,US-MO,Cost of insulin,dipeptidyl peptidase 4 inhibitors,Kussmaul breathing,get involved,Aldesleukin,Diabetes Care,Bolus Basel,GLP-1 agonists,LADA,Biomarkers and Imaging,Robert Wood Johnson IV,high blood glucose,TrialNet,Special Diabetes Program,A1C Test,cholesterol levels,Diabetes Complications,brittle diabetes,Non-Profit Foundation,implantable insulin pump,Regular.